Jenburkt Pharmaceuticals standalone net profit rises 5.83% in the September 2025 quarter
Sales rise 10.53% to Rs 45.56 crore
Net profit of Jenburkt Pharmaceuticals rose 5.83% to Rs 10.16 crore in the quarter ended September 2025 as against Rs 9.60 crore during the previous quarter ended September 2024. Sales rose 10.53% to Rs 45.56 crore in the quarter ended September 2025 as against Rs 41.22 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales45.5641.22 11 OPM %28.7527.73 -PBDT15.0713.16 15 PBT14.3312.52 14 NP10.169.60 6Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 29 2025 | 7:49 AM IST